PER 1.18% 8.4¢ percheron therapeutics limited

For General Information, page-2663

  1. 4,318 Posts.
    lightbulb Created with Sketch. 2019
    Givinostat also has been tested in adults with Becker muscular dystrophy. Top-line results from a Phase 2 trial (NCT03238235) showed that treatment failed to reduce muscle scarring, a main trial goal, but its use stopped further muscle shrinkage and fat infiltration, suggesting it may slow or prevent disease progression.

    I wasnt correct in what I said about the adult trial.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.